gvtcx

STH5841 Drug storage and distribution for research study - STH20710

Sheffield Teaching Hospitals NHS Foundation Trust Published 10 Jul 2023 Contracts Finder

key details

Value£73,258
Statuscomplete
Category (CPV) 60130000
RegionYorkshire and the Humber
Deadline10 Jul 2023
Contract start17 Jul 2023
Contract end21 Jul 2023
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-b3472db5-cf52-4236-aecf-26360c6d8c06

Award

SupplierValueDateStatus
ROYAL FREE LONDON NHS FOUNDATION TRUST (PHARMACY) £73,258 7 Jun 2023 active

description

GUSTO (STH20772) is a study for bladder cancer patients. Patients will be randomised to receive either standard care or the intervention treatment, which is selected following gene expression subtyping. Some of the patients on the intervention arm will receive the two drugs Durvalumab & Tremelimumab. Durvalumab & Tremelimumab are being provided free of charge by AstraZeneca, however, they will need to be stored and distritubed to 20 UK sites (including STH) over a 4 year period. The aim of the study is to obtain information to understand whether this approach could improve outcomes and to guide the design of a larger subsequent trial.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 Jul 2023 Award (award) · b3515af5-d325-47e5-8ec2-269837d99de3-661250

more from Sheffield Teaching Hospitals NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.